Formerly considered fat storage, adipose tissue is now recognized as a vital endocrine organ. Dysfunction in the tissue is linked to significant cardiovascular and metabolic diseases. In the study ...
Telmisartan, an angiotensin II type 1 receptor blocker with partial PPARĪ³ agonism, has emerged as a multifunctional agent improving insulin sensitivity and modulating adipose tissue physiology. By ...
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people develop metabolic diseases of this kind. About a quarter of all obese ...
Understanding how fat tissue forms and functions is crucial for addressing obesity and related metabolic diseases. However, adipose tissue, or body fat, behaves differently based on its location in ...
A recent study published in the journal Nature Reviews Endocrinology summarized the challenges associated with adiposity assessment in clinical settings. Obesity increases cardiometabolic risks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results